Better sleep, harder mornings: a sleep drug trial

If a sleep medication helps you sleep, it is doing its job. A clinical trial published this month complicates that simple picture in a way worth understanding.

Researchers at Flinders University ran a small randomized, placebo controlled trial on low dose quetiapine, an antipsychotic that is frequently prescribed off label as a sleep aid. Fifteen adults, all living with obstructive sleep apnea and difficulty staying asleep, each spent two nights in a sleep laboratory, one after a 50 milligram dose and one after a placebo, with neither the participants nor the assessors knowing which was which (Annals of the American Thoracic Society, 2026).

On the surface the drug worked. It modestly improved sleep and even reduced the severity of the participants' sleep apnea. The catch arrived the next morning. Alertness and driving performance were measurably worse the day after the quetiapine night than after the placebo night. The researchers concluded that someone taking the drug should avoid driving for at least nine and a half hours afterward, a window that has not closed for a person who takes a tablet at ten at night and wakes at half past six (Flinders University, 2026). More than three quarters of participants reported a side effect after a single dose, and because women tend to clear quetiapine more slowly, the lingering next day effects can be stronger for them.

This was a small study, fifteen people, two nights each, and the authors are clear that larger trials are needed before drawing firm conclusions. It also looked at people with sleep apnea specifically, not garden variety insomnia. But it lands in a real world context the researchers were pointed about. In their setting, they note, the large majority of people who turn up with insomnia leave with a prescription rather than a proper sleep assessment. A drug reached for that casually deserves to have its costs measured, and this trial measured one that rarely makes it into the conversation.

What the night number hides

The headline writes itself: a sleep pill that makes you a worse driver. The quieter and more useful finding is the one underneath it. The drug improved the things we measure at night, more sleep and less apnea, and still left people worse off during the day. That gap is the whole point. We have built a habit of judging sleep by the night alone, by hours logged or a score on a watch, when the thing we actually care about is how we think, feel, and move the next day. A treatment can push the nighttime numbers in the right direction and push the daytime experience in the wrong one.

This is not an argument against medication, which has its place and is a decision for you and your doctor. It is an argument for watching the right outcome. Plenty of people who sleep a respectable number of hours still wake unrested, stiff, and braced, and plenty of the tension that fragments a night is the same tension carried through the day. You can read more about that loop in our Feldypedia entry on sleep disruption and physical tension.

It is worth knowing, too, that for chronic insomnia the treatment with the strongest evidence is not a drug at all. Clinical guidelines from the American Academy of Sleep Medicine name cognitive behavioral therapy for insomnia, a structured behavioral approach, as the first line option, with medication reserved for when that is unavailable or not enough (American Academy of Sleep Medicine, 2021).

Where gentle movement fits

I teach the Feldenkrais Method®, which is movement education rather than treatment, so I want to be careful about what it can and cannot claim. It does not cure insomnia and it is not a substitute for medical care. What it works on is the part of sleep that sits upstream of the night, the nervous system's capacity to come down out of a state of readiness. So much of poor sleep is a body that cannot stop bracing, a breath held high in the chest, a back that will not let go even lying down.

Awareness Through Movement®, the spoken lessons at the heart of the method, are slow and undemanding by design. The aim is not to tire you out but to let the nervous system register that nothing needs guarding right now, which is the same shift a good wind down is reaching for. People often notice their breathing settle lower and slower without being told to change it. If your breath tends to sit high and tight, our entry on chronic shallow breathing is a reasonable place to start.

What to take from this

If you take a sleep medication, this trial is not a reason to stop. It is a reason to watch the morning as closely as the night, and to raise next day grogginess or any sense of being slow behind the wheel with the person who prescribed it, especially if you are a woman or you drive early. The decision about the drug belongs to you and your clinician, together.

What sits outside that decision, and is worth doing either way, is building the body's own capacity to settle. Better sleep is not really the goal. A better day is, and the two are not always the same thing. Slow, attentive movement is one quiet way to give the nervous system the safety it needs to rest, no prescription required.